nodes	percent_of_prediction	percent_of_DWPC	metapath
Stavudine—Peripheral sensory neuropathy—Sorafenib—liver cancer	0.0482	0.05	CcSEcCtD
Stavudine—Zidovudine—TERT—liver cancer	0.0327	0.898	CrCbGaD
Stavudine—Lactic acidosis—Epirubicin—liver cancer	0.0209	0.0216	CcSEcCtD
Stavudine—Haemoglobin decreased—Sorafenib—liver cancer	0.02	0.0208	CcSEcCtD
Stavudine—Lactic acidosis—Doxorubicin—liver cancer	0.0193	0.02	CcSEcCtD
Stavudine—Peripheral sensory neuropathy—Epirubicin—liver cancer	0.0178	0.0185	CcSEcCtD
Stavudine—Endocrine disorder—Sorafenib—liver cancer	0.0166	0.0173	CcSEcCtD
Stavudine—Peripheral sensory neuropathy—Doxorubicin—liver cancer	0.0165	0.0171	CcSEcCtD
Stavudine—Polyneuropathy—Epirubicin—liver cancer	0.0156	0.0162	CcSEcCtD
Stavudine—Polyneuropathy—Doxorubicin—liver cancer	0.0145	0.015	CcSEcCtD
Stavudine—Neuropathy—Sorafenib—liver cancer	0.0129	0.0134	CcSEcCtD
Stavudine—Opportunistic infection—Epirubicin—liver cancer	0.0126	0.0131	CcSEcCtD
Stavudine—Mouth ulceration—Sorafenib—liver cancer	0.0125	0.0129	CcSEcCtD
Stavudine—Gynaecomastia—Sorafenib—liver cancer	0.0123	0.0128	CcSEcCtD
Stavudine—Opportunistic infection—Doxorubicin—liver cancer	0.0117	0.0121	CcSEcCtD
Stavudine—Hepatic function abnormal—Sorafenib—liver cancer	0.0114	0.0119	CcSEcCtD
Stavudine—Hepatic failure—Sorafenib—liver cancer	0.0111	0.0116	CcSEcCtD
Stavudine—Mood swings—Sorafenib—liver cancer	0.00948	0.00983	CcSEcCtD
Stavudine—Dry skin—Sorafenib—liver cancer	0.00917	0.00952	CcSEcCtD
Stavudine—Pancreatitis—Sorafenib—liver cancer	0.00848	0.0088	CcSEcCtD
Stavudine—Neutropenia—Sorafenib—liver cancer	0.00808	0.00839	CcSEcCtD
Stavudine—Weight decreased—Sorafenib—liver cancer	0.00782	0.00812	CcSEcCtD
Stavudine—Neuropathy peripheral—Sorafenib—liver cancer	0.00756	0.00784	CcSEcCtD
Stavudine—Jaundice—Sorafenib—liver cancer	0.00751	0.0078	CcSEcCtD
Stavudine—Stomatitis—Sorafenib—liver cancer	0.00751	0.0078	CcSEcCtD
Stavudine—Hepatobiliary disease—Sorafenib—liver cancer	0.00729	0.00757	CcSEcCtD
Stavudine—Lung disorder—Epirubicin—liver cancer	0.0072	0.00747	CcSEcCtD
Stavudine—Hepatomegaly—Epirubicin—liver cancer	0.0072	0.00747	CcSEcCtD
Stavudine—Neuritis—Epirubicin—liver cancer	0.00682	0.00708	CcSEcCtD
Stavudine—Connective tissue disorder—Sorafenib—liver cancer	0.0068	0.00706	CcSEcCtD
Stavudine—Lung disorder—Doxorubicin—liver cancer	0.00666	0.00691	CcSEcCtD
Stavudine—Hepatomegaly—Doxorubicin—liver cancer	0.00666	0.00691	CcSEcCtD
Stavudine—Fungal infection—Epirubicin—liver cancer	0.0066	0.00684	CcSEcCtD
Stavudine—Neuritis—Doxorubicin—liver cancer	0.00631	0.00655	CcSEcCtD
Stavudine—Fungal infection—Doxorubicin—liver cancer	0.0061	0.00633	CcSEcCtD
Stavudine—Blood disorder—Epirubicin—liver cancer	0.0061	0.00633	CcSEcCtD
Stavudine—Mental disorder—Sorafenib—liver cancer	0.00606	0.00629	CcSEcCtD
Stavudine—Malnutrition—Sorafenib—liver cancer	0.00602	0.00625	CcSEcCtD
Stavudine—Dysgeusia—Sorafenib—liver cancer	0.0059	0.00612	CcSEcCtD
Stavudine—Blood disorder—Doxorubicin—liver cancer	0.00564	0.00586	CcSEcCtD
Stavudine—Hyperbilirubinaemia—Epirubicin—liver cancer	0.0056	0.00581	CcSEcCtD
Stavudine—Anaemia—Sorafenib—liver cancer	0.00557	0.00578	CcSEcCtD
Stavudine—Thinking abnormal—Epirubicin—liver cancer	0.00556	0.00577	CcSEcCtD
Stavudine—Cough increased—Epirubicin—liver cancer	0.00556	0.00577	CcSEcCtD
Stavudine—Leukopenia—Sorafenib—liver cancer	0.00539	0.0056	CcSEcCtD
Stavudine—Cough—Sorafenib—liver cancer	0.00526	0.00546	CcSEcCtD
Stavudine—Inflammation—Epirubicin—liver cancer	0.00525	0.00545	CcSEcCtD
Stavudine—Hyperbilirubinaemia—Doxorubicin—liver cancer	0.00518	0.00538	CcSEcCtD
Stavudine—Thinking abnormal—Doxorubicin—liver cancer	0.00515	0.00534	CcSEcCtD
Stavudine—Cough increased—Doxorubicin—liver cancer	0.00515	0.00534	CcSEcCtD
Stavudine—Myalgia—Sorafenib—liver cancer	0.00513	0.00532	CcSEcCtD
Stavudine—Arthralgia—Sorafenib—liver cancer	0.00513	0.00532	CcSEcCtD
Stavudine—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.00509	0.00529	CcSEcCtD
Stavudine—Hepatocellular injury—Epirubicin—liver cancer	0.00509	0.00529	CcSEcCtD
Stavudine—Abnormal dreams—Epirubicin—liver cancer	0.00503	0.00522	CcSEcCtD
Stavudine—Dry mouth—Sorafenib—liver cancer	0.00502	0.00521	CcSEcCtD
Stavudine—Eructation—Epirubicin—liver cancer	0.005	0.00519	CcSEcCtD
Stavudine—Inflammation—Doxorubicin—liver cancer	0.00486	0.00504	CcSEcCtD
Stavudine—Nervous system disorder—Sorafenib—liver cancer	0.00482	0.005	CcSEcCtD
Stavudine—Thrombocytopenia—Sorafenib—liver cancer	0.00481	0.005	CcSEcCtD
Stavudine—Neuropathy—Epirubicin—liver cancer	0.00478	0.00496	CcSEcCtD
Stavudine—Skin disorder—Sorafenib—liver cancer	0.00478	0.00496	CcSEcCtD
Stavudine—Hepatocellular injury—Doxorubicin—liver cancer	0.00471	0.00489	CcSEcCtD
Stavudine—Anorexia—Sorafenib—liver cancer	0.00469	0.00486	CcSEcCtD
Stavudine—Abnormal dreams—Doxorubicin—liver cancer	0.00466	0.00483	CcSEcCtD
Stavudine—Eructation—Doxorubicin—liver cancer	0.00463	0.0048	CcSEcCtD
Stavudine—Mouth ulceration—Epirubicin—liver cancer	0.0046	0.00478	CcSEcCtD
Stavudine—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00448	0.00465	CcSEcCtD
Stavudine—Neuropathy—Doxorubicin—liver cancer	0.00442	0.00459	CcSEcCtD
Stavudine—Mental disability—Epirubicin—liver cancer	0.00442	0.00459	CcSEcCtD
Stavudine—Dyspepsia—Sorafenib—liver cancer	0.00433	0.00449	CcSEcCtD
Stavudine—Decreased appetite—Sorafenib—liver cancer	0.00427	0.00444	CcSEcCtD
Stavudine—Mouth ulceration—Doxorubicin—liver cancer	0.00426	0.00442	CcSEcCtD
Stavudine—Diabetes mellitus—Epirubicin—liver cancer	0.00425	0.00441	CcSEcCtD
Stavudine—Gastrointestinal disorder—Sorafenib—liver cancer	0.00424	0.00441	CcSEcCtD
Stavudine—Fatigue—Sorafenib—liver cancer	0.00424	0.0044	CcSEcCtD
Stavudine—Hepatic function abnormal—Epirubicin—liver cancer	0.00423	0.00439	CcSEcCtD
Stavudine—Constipation—Sorafenib—liver cancer	0.0042	0.00436	CcSEcCtD
Stavudine—Pain—Sorafenib—liver cancer	0.0042	0.00436	CcSEcCtD
Stavudine—Hepatic failure—Epirubicin—liver cancer	0.00411	0.00427	CcSEcCtD
Stavudine—Mental disability—Doxorubicin—liver cancer	0.00409	0.00424	CcSEcCtD
Stavudine—Gastrointestinal pain—Sorafenib—liver cancer	0.00402	0.00417	CcSEcCtD
Stavudine—Diabetes mellitus—Doxorubicin—liver cancer	0.00393	0.00408	CcSEcCtD
Stavudine—Hepatic function abnormal—Doxorubicin—liver cancer	0.00391	0.00406	CcSEcCtD
Stavudine—Urticaria—Sorafenib—liver cancer	0.00391	0.00405	CcSEcCtD
Stavudine—Abdominal pain—Sorafenib—liver cancer	0.00389	0.00403	CcSEcCtD
Stavudine—Body temperature increased—Sorafenib—liver cancer	0.00389	0.00403	CcSEcCtD
Stavudine—Hepatic failure—Doxorubicin—liver cancer	0.00381	0.00395	CcSEcCtD
Stavudine—Zidovudine—ALB—liver cancer	0.00373	0.103	CrCbGaD
Stavudine—Affect lability—Epirubicin—liver cancer	0.00364	0.00378	CcSEcCtD
Stavudine—Hypersensitivity—Sorafenib—liver cancer	0.00362	0.00376	CcSEcCtD
Stavudine—Asthenia—Sorafenib—liver cancer	0.00353	0.00366	CcSEcCtD
Stavudine—Mood swings—Epirubicin—liver cancer	0.0035	0.00363	CcSEcCtD
Stavudine—Pruritus—Sorafenib—liver cancer	0.00348	0.00361	CcSEcCtD
Stavudine—Dry skin—Epirubicin—liver cancer	0.00339	0.00352	CcSEcCtD
Stavudine—Affect lability—Doxorubicin—liver cancer	0.00337	0.00349	CcSEcCtD
Stavudine—Diarrhoea—Sorafenib—liver cancer	0.00336	0.00349	CcSEcCtD
Stavudine—Dizziness—Sorafenib—liver cancer	0.00325	0.00337	CcSEcCtD
Stavudine—Mood swings—Doxorubicin—liver cancer	0.00324	0.00336	CcSEcCtD
Stavudine—Influenza—Epirubicin—liver cancer	0.0032	0.00332	CcSEcCtD
Stavudine—Dry skin—Doxorubicin—liver cancer	0.00314	0.00325	CcSEcCtD
Stavudine—Pancreatitis—Epirubicin—liver cancer	0.00313	0.00325	CcSEcCtD
Stavudine—Vomiting—Sorafenib—liver cancer	0.00313	0.00324	CcSEcCtD
Stavudine—Rash—Sorafenib—liver cancer	0.0031	0.00322	CcSEcCtD
Stavudine—Dermatitis—Sorafenib—liver cancer	0.0031	0.00321	CcSEcCtD
Stavudine—Headache—Sorafenib—liver cancer	0.00308	0.0032	CcSEcCtD
Stavudine—Bronchitis—Epirubicin—liver cancer	0.00307	0.00319	CcSEcCtD
Stavudine—Neutropenia—Epirubicin—liver cancer	0.00299	0.0031	CcSEcCtD
Stavudine—Dysuria—Epirubicin—liver cancer	0.00299	0.0031	CcSEcCtD
Stavudine—Influenza—Doxorubicin—liver cancer	0.00296	0.00307	CcSEcCtD
Stavudine—Nausea—Sorafenib—liver cancer	0.00292	0.00303	CcSEcCtD
Stavudine—Pancreatitis—Doxorubicin—liver cancer	0.0029	0.00301	CcSEcCtD
Stavudine—Weight decreased—Epirubicin—liver cancer	0.00289	0.003	CcSEcCtD
Stavudine—Hyperglycaemia—Epirubicin—liver cancer	0.00288	0.00299	CcSEcCtD
Stavudine—Bronchitis—Doxorubicin—liver cancer	0.00284	0.00295	CcSEcCtD
Stavudine—Neuropathy peripheral—Epirubicin—liver cancer	0.00279	0.0029	CcSEcCtD
Stavudine—Stomatitis—Epirubicin—liver cancer	0.00278	0.00288	CcSEcCtD
Stavudine—Jaundice—Epirubicin—liver cancer	0.00278	0.00288	CcSEcCtD
Stavudine—Conjunctivitis—Epirubicin—liver cancer	0.00277	0.00287	CcSEcCtD
Stavudine—Urinary tract infection—Epirubicin—liver cancer	0.00277	0.00287	CcSEcCtD
Stavudine—Dysuria—Doxorubicin—liver cancer	0.00276	0.00287	CcSEcCtD
Stavudine—Neutropenia—Doxorubicin—liver cancer	0.00276	0.00287	CcSEcCtD
Stavudine—Sweating—Epirubicin—liver cancer	0.00273	0.00283	CcSEcCtD
Stavudine—Haematuria—Epirubicin—liver cancer	0.00272	0.00282	CcSEcCtD
Stavudine—Hepatobiliary disease—Epirubicin—liver cancer	0.00269	0.0028	CcSEcCtD
Stavudine—Weight decreased—Doxorubicin—liver cancer	0.00267	0.00278	CcSEcCtD
Stavudine—Sinusitis—Epirubicin—liver cancer	0.00267	0.00277	CcSEcCtD
Stavudine—Hyperglycaemia—Doxorubicin—liver cancer	0.00267	0.00277	CcSEcCtD
Stavudine—Neuropathy peripheral—Doxorubicin—liver cancer	0.00258	0.00268	CcSEcCtD
Stavudine—Jaundice—Doxorubicin—liver cancer	0.00257	0.00267	CcSEcCtD
Stavudine—Stomatitis—Doxorubicin—liver cancer	0.00257	0.00267	CcSEcCtD
Stavudine—Rhinitis—Epirubicin—liver cancer	0.00256	0.00266	CcSEcCtD
Stavudine—Urinary tract infection—Doxorubicin—liver cancer	0.00256	0.00266	CcSEcCtD
Stavudine—Conjunctivitis—Doxorubicin—liver cancer	0.00256	0.00266	CcSEcCtD
Stavudine—Hepatitis—Epirubicin—liver cancer	0.00256	0.00265	CcSEcCtD
Stavudine—Hypoaesthesia—Epirubicin—liver cancer	0.00254	0.00264	CcSEcCtD
Stavudine—Pharyngitis—Epirubicin—liver cancer	0.00254	0.00263	CcSEcCtD
Stavudine—Sweating—Doxorubicin—liver cancer	0.00253	0.00262	CcSEcCtD
Stavudine—Haematuria—Doxorubicin—liver cancer	0.00251	0.00261	CcSEcCtD
Stavudine—Connective tissue disorder—Epirubicin—liver cancer	0.00251	0.00261	CcSEcCtD
Stavudine—Hepatobiliary disease—Doxorubicin—liver cancer	0.00249	0.00259	CcSEcCtD
Stavudine—Sinusitis—Doxorubicin—liver cancer	0.00247	0.00257	CcSEcCtD
Stavudine—Rhinitis—Doxorubicin—liver cancer	0.00237	0.00246	CcSEcCtD
Stavudine—Hepatitis—Doxorubicin—liver cancer	0.00237	0.00246	CcSEcCtD
Stavudine—Hypoaesthesia—Doxorubicin—liver cancer	0.00235	0.00244	CcSEcCtD
Stavudine—Pharyngitis—Doxorubicin—liver cancer	0.00235	0.00244	CcSEcCtD
Stavudine—Connective tissue disorder—Doxorubicin—liver cancer	0.00233	0.00241	CcSEcCtD
Stavudine—Chills—Epirubicin—liver cancer	0.00229	0.00238	CcSEcCtD
Stavudine—Mental disorder—Epirubicin—liver cancer	0.00224	0.00233	CcSEcCtD
Stavudine—Malnutrition—Epirubicin—liver cancer	0.00223	0.00231	CcSEcCtD
Stavudine—Flatulence—Epirubicin—liver cancer	0.00219	0.00228	CcSEcCtD
Stavudine—Dysgeusia—Epirubicin—liver cancer	0.00218	0.00226	CcSEcCtD
Stavudine—Back pain—Epirubicin—liver cancer	0.00215	0.00223	CcSEcCtD
Stavudine—Chills—Doxorubicin—liver cancer	0.00212	0.0022	CcSEcCtD
Stavudine—Mental disorder—Doxorubicin—liver cancer	0.00207	0.00215	CcSEcCtD
Stavudine—Malnutrition—Doxorubicin—liver cancer	0.00206	0.00214	CcSEcCtD
Stavudine—Anaemia—Epirubicin—liver cancer	0.00206	0.00214	CcSEcCtD
Stavudine—Flatulence—Doxorubicin—liver cancer	0.00203	0.00211	CcSEcCtD
Stavudine—Dysgeusia—Doxorubicin—liver cancer	0.00202	0.00209	CcSEcCtD
Stavudine—Leukopenia—Epirubicin—liver cancer	0.00199	0.00207	CcSEcCtD
Stavudine—Back pain—Doxorubicin—liver cancer	0.00199	0.00207	CcSEcCtD
Stavudine—Cough—Epirubicin—liver cancer	0.00194	0.00202	CcSEcCtD
Stavudine—Anaemia—Doxorubicin—liver cancer	0.0019	0.00198	CcSEcCtD
Stavudine—Myalgia—Epirubicin—liver cancer	0.0019	0.00197	CcSEcCtD
Stavudine—Arthralgia—Epirubicin—liver cancer	0.0019	0.00197	CcSEcCtD
Stavudine—Anxiety—Epirubicin—liver cancer	0.00189	0.00196	CcSEcCtD
Stavudine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.00188	0.00195	CcSEcCtD
Stavudine—Dry mouth—Epirubicin—liver cancer	0.00185	0.00192	CcSEcCtD
Stavudine—Leukopenia—Doxorubicin—liver cancer	0.00184	0.00191	CcSEcCtD
Stavudine—Cough—Doxorubicin—liver cancer	0.0018	0.00187	CcSEcCtD
Stavudine—Nervous system disorder—Epirubicin—liver cancer	0.00178	0.00185	CcSEcCtD
Stavudine—Thrombocytopenia—Epirubicin—liver cancer	0.00178	0.00185	CcSEcCtD
Stavudine—Skin disorder—Epirubicin—liver cancer	0.00176	0.00183	CcSEcCtD
Stavudine—Hyperhidrosis—Epirubicin—liver cancer	0.00176	0.00182	CcSEcCtD
Stavudine—Arthralgia—Doxorubicin—liver cancer	0.00175	0.00182	CcSEcCtD
Stavudine—Myalgia—Doxorubicin—liver cancer	0.00175	0.00182	CcSEcCtD
Stavudine—Anxiety—Doxorubicin—liver cancer	0.00175	0.00181	CcSEcCtD
Stavudine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.00174	0.00181	CcSEcCtD
Stavudine—Anorexia—Epirubicin—liver cancer	0.00173	0.0018	CcSEcCtD
Stavudine—Dry mouth—Doxorubicin—liver cancer	0.00172	0.00178	CcSEcCtD
Stavudine—Musculoskeletal discomfort—Epirubicin—liver cancer	0.00166	0.00172	CcSEcCtD
Stavudine—Nervous system disorder—Doxorubicin—liver cancer	0.00165	0.00171	CcSEcCtD
Stavudine—Thrombocytopenia—Doxorubicin—liver cancer	0.00165	0.00171	CcSEcCtD
Stavudine—Insomnia—Epirubicin—liver cancer	0.00164	0.00171	CcSEcCtD
Stavudine—Skin disorder—Doxorubicin—liver cancer	0.00163	0.00169	CcSEcCtD
Stavudine—Paraesthesia—Epirubicin—liver cancer	0.00163	0.00169	CcSEcCtD
Stavudine—Hyperhidrosis—Doxorubicin—liver cancer	0.00163	0.00169	CcSEcCtD
Stavudine—Somnolence—Epirubicin—liver cancer	0.00162	0.00168	CcSEcCtD
Stavudine—Anorexia—Doxorubicin—liver cancer	0.0016	0.00166	CcSEcCtD
Stavudine—Dyspepsia—Epirubicin—liver cancer	0.0016	0.00166	CcSEcCtD
Stavudine—Decreased appetite—Epirubicin—liver cancer	0.00158	0.00164	CcSEcCtD
Stavudine—Gastrointestinal disorder—Epirubicin—liver cancer	0.00157	0.00163	CcSEcCtD
Stavudine—Fatigue—Epirubicin—liver cancer	0.00157	0.00163	CcSEcCtD
Stavudine—Pain—Epirubicin—liver cancer	0.00155	0.00161	CcSEcCtD
Stavudine—Constipation—Epirubicin—liver cancer	0.00155	0.00161	CcSEcCtD
Stavudine—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.00153	0.00159	CcSEcCtD
Stavudine—Insomnia—Doxorubicin—liver cancer	0.00152	0.00158	CcSEcCtD
Stavudine—Paraesthesia—Doxorubicin—liver cancer	0.00151	0.00157	CcSEcCtD
Stavudine—Somnolence—Doxorubicin—liver cancer	0.00149	0.00155	CcSEcCtD
Stavudine—Gastrointestinal pain—Epirubicin—liver cancer	0.00149	0.00154	CcSEcCtD
Stavudine—Dyspepsia—Doxorubicin—liver cancer	0.00148	0.00154	CcSEcCtD
Stavudine—Decreased appetite—Doxorubicin—liver cancer	0.00146	0.00152	CcSEcCtD
Stavudine—Gastrointestinal disorder—Doxorubicin—liver cancer	0.00145	0.00151	CcSEcCtD
Stavudine—Fatigue—Doxorubicin—liver cancer	0.00145	0.0015	CcSEcCtD
Stavudine—Urticaria—Epirubicin—liver cancer	0.00144	0.0015	CcSEcCtD
Stavudine—Pain—Doxorubicin—liver cancer	0.00144	0.00149	CcSEcCtD
Stavudine—Constipation—Doxorubicin—liver cancer	0.00144	0.00149	CcSEcCtD
Stavudine—Abdominal pain—Epirubicin—liver cancer	0.00144	0.00149	CcSEcCtD
Stavudine—Body temperature increased—Epirubicin—liver cancer	0.00144	0.00149	CcSEcCtD
Stavudine—Gastrointestinal pain—Doxorubicin—liver cancer	0.00137	0.00143	CcSEcCtD
Stavudine—Hypersensitivity—Epirubicin—liver cancer	0.00134	0.00139	CcSEcCtD
Stavudine—Urticaria—Doxorubicin—liver cancer	0.00134	0.00139	CcSEcCtD
Stavudine—Abdominal pain—Doxorubicin—liver cancer	0.00133	0.00138	CcSEcCtD
Stavudine—Body temperature increased—Doxorubicin—liver cancer	0.00133	0.00138	CcSEcCtD
Stavudine—Asthenia—Epirubicin—liver cancer	0.0013	0.00135	CcSEcCtD
Stavudine—Pruritus—Epirubicin—liver cancer	0.00129	0.00133	CcSEcCtD
Stavudine—Diarrhoea—Epirubicin—liver cancer	0.00124	0.00129	CcSEcCtD
Stavudine—Hypersensitivity—Doxorubicin—liver cancer	0.00124	0.00129	CcSEcCtD
Stavudine—Asthenia—Doxorubicin—liver cancer	0.00121	0.00125	CcSEcCtD
Stavudine—Dizziness—Epirubicin—liver cancer	0.0012	0.00125	CcSEcCtD
Stavudine—Pruritus—Doxorubicin—liver cancer	0.00119	0.00123	CcSEcCtD
Stavudine—Vomiting—Epirubicin—liver cancer	0.00116	0.0012	CcSEcCtD
Stavudine—Diarrhoea—Doxorubicin—liver cancer	0.00115	0.00119	CcSEcCtD
Stavudine—Rash—Epirubicin—liver cancer	0.00115	0.00119	CcSEcCtD
Stavudine—Dermatitis—Epirubicin—liver cancer	0.00114	0.00119	CcSEcCtD
Stavudine—Headache—Epirubicin—liver cancer	0.00114	0.00118	CcSEcCtD
Stavudine—Dizziness—Doxorubicin—liver cancer	0.00111	0.00115	CcSEcCtD
Stavudine—Nausea—Epirubicin—liver cancer	0.00108	0.00112	CcSEcCtD
Stavudine—Vomiting—Doxorubicin—liver cancer	0.00107	0.00111	CcSEcCtD
Stavudine—Rash—Doxorubicin—liver cancer	0.00106	0.0011	CcSEcCtD
Stavudine—Dermatitis—Doxorubicin—liver cancer	0.00106	0.0011	CcSEcCtD
Stavudine—Headache—Doxorubicin—liver cancer	0.00105	0.00109	CcSEcCtD
Stavudine—Nausea—Doxorubicin—liver cancer	0.000999	0.00104	CcSEcCtD
